Human immune system mice: Current potential and limitations for translational research on human antibody responses

Immunologic Research

Volumn 51, Issue 2-3, 2011, Pages 257-266

  Vuyyuru, Raja ^a   Patton, John ^a   Manser, Tim ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Antibody responses; B lymphocytes; Chimeric mice; Human immune system; Secondary lymphoid organs

Indexed keywords

ANTIBODY; B LYMPHOCYTE ANTIGEN; INTERLEUKIN 7; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; POLYSACCHARIDE; PURIFIED POLYSACCHARIDE ANTIGEN; RECOMBINANT INTERLEUKIN 7; T LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; BONE MARROW; BORRELIA HERMSII; CELL COMPARTMENTALIZATION; CELL FUNCTION; CELL MATURATION; CONTROLLED STUDY; FOLLICULAR DENDRITIC CELL; HELPER CELL; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; HUMAN IMMUNE SYSTEM; IMMUNE SYSTEM; IMMUNIZATION; LYMPHOCYTE SUBPOPULATION; LYMPHOID ORGAN; MICROENVIRONMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; SHEEP ERYTHROCYTE; TRANSLATIONAL RESEARCH;

ADULT STEM CELLS; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODY FORMATION; B-LYMPHOCYTES; CELL DIFFERENTIATION; CHIMERA; HUMANS; IMMUNE SYSTEM; LYMPHOCYTE ACTIVATION; MICE; MODELS, ANIMAL; POLYSACCHARIDES, BACTERIAL; T-LYMPHOCYTES, HELPER-INDUCER; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84856545139     PISSN: 0257277X     EISSN: 15590755     Source Type: Journal    
DOI: 10.1007/s12026-011-8243-9     Document Type: Article

References (68)

1. Bosma GC, Custer RP, Bosma MJ. A severe combined immunodeficiency mutation in the mouse. Nature. 1983;301(5900): 527-30. (Pubitemid 13160576)
2. McCune JM, Kaneshima H, Lieberman M, Weissman IL, Namikawa R. The scid-hu mouse: Current status and potential applications. Curr Top Microbiol Immunol. 1989;152:183-93.
3. Torbett BE, Picchio G, Mosier DE. hu-PBL-SCID mice: A model for human immune function, AIDS, and lymphomagenesis. Immunol Rev. 1991;124:139-64.
4. Kraft DL, Weissman IL, Waller EK. Differentiation of CD3-4-8- human fetal thymocytes in vivo: Characterization of a CD3-4 ? 8- intermediate. J Exp Med. 1993;178(1):265-77.
5. Weissman IL, Shizuru JA. The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases. Blood. 2008;112(9):3543-53.
6. Greiner DL, Hesselton RA, Shultz LD. SCID mouse models of human stem cell engraftment. Stem Cells. 1998;16(3):166-77. (Pubitemid 28235161)
7. Lapidot T, Pflumio F, Doedens M, Murdoch B, Williams DE, Dick JE. Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice. Science. 1992;255(5048):1137-41.
8. Dick JE, Bhatia M, Gan O, Kapp U, Wang JC. Assay of human stem cells by repopulation of NOD/SCID mice. Stem Cells. 1997;15(Suppl 1):199-203. discussion 4-7.
9. Shultz LD, Schweitzer PA, Christianson SW, Gott B, Schweitzer IB, Tennent B, McKenna S, Mobraaten L, Rajan TV, Greiner DL, et al. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol. 1995;154(1): 180-91.
10. Christianson SW, Greiner DL, Schweitzer IB, Gott B, Beamer GL, Schweitzer PA, Hesselton RM, Shultz LD. Role of natural killer cells on engraftment of human lymphoid cells and on metastasis of human T-lymphoblastoid leukemia cells in C57BL/ 6 J-scid mice and in C57BL/6 J-scid bg mice. Cell Immunol. 1996;171(2):186-99. (Pubitemid 26268474)
11. DiSanto JP, Muller W, Guy-Grand D, Fischer A, Rajewsky K. Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain. Proc Natl Acad Sci USA. 1995;92(2):377-81.
12. Cao X, Shores EW, Hu-Li J, Anver MR, Kelsall BL, Russell SM, Drago J, Noguchi M, Grinberg A, Bloom ET, et al. Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. Immunity. 1995;2(3): 223-38.
13. Manz MG. Human-hemato-lymphoid-system mice: Opportunities and challenges. Immunity. 2007;26(5):537-41. (Pubitemid 46756351)
14. Shultz LD, Ishikawa F, Greiner DL. Humanized mice in translational biomedical research. Nat Rev Immunol. 2007;7(2): 118-30. (Pubitemid 46174859)
15. Legrand N, Weijer K, Spits H. Experimental models to study development and function of the human immune system in vivo. J Immunol. 2006;176(4):2053-8. (Pubitemid 43201649)
16. Yokoyama WM, Kim S, French AR. The dynamic life of natural killer cells. Annu Rev Immunol. 2004;22:405-29. (Pubitemid 38680428)
17. Loza MJ, Perussia B. Final steps of natural killer cell maturation: A model for type 1-type 2 differentiation? Nat Immunol. 2001; 2(10):917-24.
18. Takenaka K, Prasolava TK,Wang JC, Mortin-Toth SM, Khalouei S, Gan OI, Dick JE, Danska JS. Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells. Nat Immunol. 2007;8(12):1313-23. (Pubitemid 350138972)
19. Traggiai E, Chicha L, Mazzucchelli L, Bronz L, Piffaretti JC, Lanzavecchia A, Manz MG. Development of a human adaptive immune system in cord blood cell-transplanted mice. Science. 2004;304(5667):104-7. (Pubitemid 38451466)
20. Zhang L, Kovalev GI, Su L. HIV-1 infection and pathogenesis in a novel humanized mouse model. Blood. 2007;109(7):2978-81. (Pubitemid 46482096)
21. Baenziger S, Tussiwand R, Schlaepfer E, Mazzucchelli L, Heikenwalder M, Kurrer MO, Behnke S, Frey J, Oxenius A, Joller H, Aguzzi A, Manz MG, Speck RF. Disseminated and sustained HIV infection in CD34 ? cord blood cell-transplanted Rag2-/-gamma c-/-mice. Proc Natl Acad Sci USA. 2006; 103(43):15951-6. (Pubitemid 44657573)
22. Jaiswal S, Pearson T, Friberg H, Shultz LD, Greiner DL, Rothman AL, Mathew A. Dengue virus infection and virusspecific HLA-A2 restricted immune responses in humanized NOD-scid IL2rgammanull mice. PLoS One. 2009;4(10):e7251.
23. Melkus MW, Estes JD, Padgett-Thomas A, Gatlin J, Denton PW, Othieno FA, Wege AK, Haase AT, Garcia JV. Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nat Med. 2006;12(11):1316-22. (Pubitemid 44706935)
24. Washburn ML, Bility MT, Zhang L, Kovalev GI, Buntzman A, Frelinger JA, Barry W, Ploss A, Rice CM, Su L. A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease. Gastroenterology. 2011;140(4): 1334-44.
25. Libby SJ, Brehm MA, Greiner DL, Shultz LD, McClelland M, Smith KD, Cookson BT, Karlinsey JE, Kinkel TL, Porwollik S, Canals R, Cummings LA, Fang FC. Humanized nonobese diabetic- scid IL2rgammanull mice are susceptible to lethal Salmonella Typhi infection. Proc Natl Acad Sci USA. 2010;107(35): 15589-94.
26. Palanichamy A, Barnard J, Zheng B, Owen T, Quach T, Wei C, Looney RJ, Sanz I, Anolik JH. Novel human transitional B cell populations revealed by B cell depletion therapy. J Immunol. 2009;182(10):5982-93.
27. Chen Q, Khoury M, Chen J. Expression of human cytokines dramatically improves reconstitution of specific human-blood lineage cells in humanized mice. Proc Natl Acad Sci USA. 2009;106(51):21783-8.
28. von Freeden-Jeffry U, Vieira P, Lucian LA, McNeil T, Burdach SE, Murray R. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J Exp Med. 1995;181:1519-26.
29. van Lent AU, Dontje W, Nagasawa M, Siamari R, Bakker AQ, Pouw SM, Maijoor KA, Weijer K, Cornelissen JJ, Blom B, Di Santo JP, Spits H, Legrand N. IL-7 enhances thymic human T cell development in "human immune system" Rag2-/-IL- 2Rgammac-/-mice without affecting peripheral T cell homeostasis. J Immunol. 2009;183(12):7645-55.
30. O'Connell RM, Balazs AB, Rao DS, Kivork C, Yang L, Baltimore D. Lentiviral vector delivery of human interleukin-7 (hIL-7) to human immune system (HIS) mice expands T lymphocyte populations. PLoS One. 2010;5(8):e12009.
31. Griffin DO, Holodick NE, Rothstein TL. Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20 ? CD27 ? CD43 ? CD70. J Exp Med. 2011; 208(1):67-80.
32. Hardy RR, Hayakawa K. B cell development pathways. Annu Rev Immunol. 2001;19:595-621. (Pubitemid 32368047)
33. Tornberg UC, Holmberg D. B-1a, B-1b and B-2 B cells display uniqueVHDJHrepertoires formed atdifferent stages of ontogeny and under different selection pressures. EMBO J. 1995;14(8):1680-9.
34. Martin F, Kearney JF. B-cell subsets and the mature preimmune repertoire. Marginal zone and B1 B cells as part of a "natural immune memory". Immunol Rev. 2000;175:70-9.
35. Jeong HD, Teale JM. Comparison of the fetal and adult functional B cell repertoires by analysis of VH gene family expression. J Exp Med. 1988;168(2):589-603.
36. Malynn BA, Yancopoulos GD, Barth JE, Bona CA, Alt FW. Biased expression of JH-proximal VH genes occurs in the newly generated repertoire of neonatal and adult mice. J Exp Med. 1990;171(3):843-59. (Pubitemid 20088986)
37. Cyster JG. Lymphoid organ development and cell migration. Immunol Rev. 2003;195:5-14. (Pubitemid 37153449)
38. Germain RN. The art of the probable: System control in the adaptive immune system. Science. 2001;293(5528):240-5. (Pubitemid 32694729)
39. Mebius RE, Kraal G. Structure and function of the spleen. Nat Rev Immunol. 2005;5(8):606-16. (Pubitemid 41113192)
40. Vondenhoff MF, Kraal G, Mebius RE. Lymphoid organogenesis in brief. Eur J Immunol. 2007;37(Suppl 1):S46-52. (Pubitemid 350131267)
41. Ruddle NH, Akirav EM. Secondary lymphoid organs: Responding to genetic and environmental cues in ontogeny and the immune response. J Immunol. 2009;183(4):2205-12.
42. Ngo VN, Cornall RJ, Cyster JG. Splenic T zone development is B cell dependent. J Exp Med. 2001;194(11):1649-60. (Pubitemid 33126815)
43. Koni PA, Sacca R, Lawton P, Browning JL, Ruddle NH, Flavell RA. Distinct roles in lymphoid organogenesis for lymphotoxins alpha and beta revealed in lymphotoxin beta-deficient mice. Immunity. 1997;6(4):491-500. (Pubitemid 27208204)
44. Ansel KM, Ngo VN, Hyman PL, Luther SA, Forster R, Sedgwick JD, Browning JL, Lipp M, Cyster JG. A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature. 2000;406(6793):309-14. (Pubitemid 30604409)
45. Forster R, Mattis AE, Kremmer E, Wolf E, Brem G, Lipp M. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell. 1996;87(6):1037-47. (Pubitemid 26427987)
46. Ishikawa F, Yasukawa M, Lyons B, Yoshida S, Miyamoto T, Yoshimoto G, Watanabe T, Akashi K, Shultz LD, Harada M. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor gamma chain(null) mice. Blood. 2005;106(5):1565-73. (Pubitemid 41208567)
47. Monroe JG, Bannish G, Fuentes-Panana EM, King LB, Sandel PC, Chung J, Sater R. Positive and negative selection during B lymphocyte development. Immunol Res. 2003;27(2-3): 427-42.
48. Cambier JC, Gauld SB, Merrell KT, Vilen BJ. B-cell anergy: From transgenic models to naturally occurring anergic B cells? Nat Rev Immunol. 2007;7(8):633-43.
49. Andrews SF, Wilson PC. The anergic B cell. Blood. 2010;115(24):4976-8.
50. Danner R, Chaudhari SN, Rosenberger J, Surls J, Richie TL, Brumeanu TD, Casares S. Expression of HLA class II molecules in humanized NOD.Rag1KO.IL2RgcKO mice is critical for development and function of human T and B cells. PLoS One. 2011;6(5):e19826.
51. Szakal AK, Kapasi ZF, Haley ST, Tew JG. A theory of follicular dendritic cell origin. Curr Top Microbiol Immunol. 1995;201:1-13.
52. Gommerman JL, Mackay F, Donskoy E, Meier W, Martin P, Browning JL. Manipulation of lymphoid microenvironments in nonhuman primates by an inhibitor of the lymphotoxin pathway. J Clin Invest. 2002;110(9):1359-69. (Pubitemid 35285762)
53. Mackay F, Browning JL. Turning off follicular dendritic cells. Nature. 1998;395(6697):26-7.
54. Alugupalli KR, Gerstein RM, Chen J, Szomolanyi-Tsuda E, Woodland RT, Leong JM. The resolution of relapsing fever borreliosis requires IgM and is concurrent with expansion of B1b lymphocytes. J Immunol. 2003;170(7):3819-27. (Pubitemid 36359252)
55. Alugupalli KR, Michelson AD, Joris I, Schwan TG, Hodivala- Dilke K, Hynes RO, Leong JM. Spirochete-platelet attachment and thrombocytopenia in murine relapsing fever borreliosis. Blood. 2003;102(8):2843-50. (Pubitemid 37248855)
56. Barbour AG. Antigenic variation of a relapsing fever Borrelia species. Annu Rev Microbiol. 1990;44:155-71.
57. Barbour AG, Bundoc V. In vitro and in vivo neutralization of the relapsing fever agent Borrelia hermsii with serotype-specific immunoglobulin M antibodies. Infect Immun. 2001;69(2): 1009-15.
58. Barbour AG, Bundoc V. In vitro and in vivo neutralization of the relapsing fever agent Borrelia hermsii with serotype-specific immunoglobulin M antibodies. Infect Immun. 2001;69: 1009-15. (Pubitemid 32109568)
59. Alugupalli KR, Gerstein RM, Chen J, Szomolanyi-Tsuda E, Woodland RT, Leong JM. The resolution of relapsing fever Borreliosis requires IgM and is concurrent with expansion of B1b lymphocytes. J Immunol. 2003;170:3819-27. (Pubitemid 36359252)
60. Alugupalli KR, Leong JM, Woodland RT, Muramatsu M, Honjo T, Gerstein RM. B1b Lymphocytes confer T cell-independent long-lasting immunity. Immunity. 2004;21:379-90. (Pubitemid 39208339)
61. Connolly SE, Benach JL. The versatile roles of antibodies in Borrelia infections. Nat Rev Microbiol. 2005;3(5):411-20. (Pubitemid 40590383)
62. Martin F, Kearney JF. B1 cells: Similarities and differences with other B cell subsets. Curr Opin Immunol. 2001;13:195-201. (Pubitemid 32176039)
63. Alugupalli KR. A distinct role for B1b lymphocytes in T cellindependent immunity. Curr Top Microbiol Immunol. 2008; 319:105-30.
64. Martin F, Oliver AM, Kearney JF. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity. 2001;14(5):617-29. (Pubitemid 32520872)
65. Vos Q, Lees A, Wu ZQ, Snapper CM, Mond JJ. B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms. Immunol Rev. 2000;176:154-70.
66. Gonzalez-Fernandez A, Faro J, Fernandez C. Immune responses to polysaccharides: Lessons from humans and mice. Vaccine. 2008;26(3):292-300.
67. Landers CD, Chelvarajan RL, Bondada S. The role of B cells and accessory cells in the neonatal response to TI-2 antigens. Immunol Res. 2005;31(1):25-36. (Pubitemid 40065422)
68. Dickinson GS, Piccone H, Sun G, Lien E, Gatto L, Alugupalli KR. Toll-like receptor 2 deficiency results in impaired antibody responses and septic shock during Borrelia hermsii infection. Infect Immun. 2010;78(11):4579-88.